PURPOSE OF REVIEW:
Intestinal helminth infections continue to cause significant morbidity in resource-limited settings. Recent efforts at global control have centered on mass drug administration (MDA) of praziquantel and benzimidazole anthelminthics to reduce the prevalence and intensity of schistosomiasis and soil-transmitted nematode infections, respectively. This review summarizes progress and potential challenges associated with MDA.
Data from studies conducted in endemic areas show that chemotherapeutic interventions can reduce prevalence and intensity of infection with intestinal helminths, and have the potential to reduce trans...